Treatment of Chemotherapy-Induced Peripheral Neuropathy: Systematic Review and Recommendations

被引:9
作者
Hou, Saiyun [1 ]
Huh, Billy [1 ]
Kim, Hee Kee [1 ]
Kim, Kyung-Hoon [2 ]
Abdi, Salahadin [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Pain Med, 1400 Holcombe Blvd,Unit 0409, Houston, TX 77030 USA
[2] Pusan Natl Univ, Pusan, South Korea
关键词
Chemotherapy-induced neuropathy; peripheral neuropathy; chemotherapy-tumor; neuropathic pain; chronic pain; toxicology; treatment; reduction of pain; level of evidence; EVIDENCE-BASED GUIDELINE; QUALITY-OF-LIFE; INDUCED POLYNEUROPATHY; DOUBLE-BLIND; SCRAMBLER THERAPY; AMERICAN ACADEMY; CONTROLLED-TRIAL; PILOT TRIAL; PAIN; ACUPUNCTURE;
D O I
暂无
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a commonly encountered disease entity following chemotherapy for cancer treatment. Although only duloxetine is recommended by the American Society of Clinical Oncology (ASCO) for the treatment of CIPN in 2014, the evidence of the clinical outcome for new pharmaceutic therapies and non-pharmaceutic treatments has not been clearly determined. Objective: To provide a comprehensive review and evidence-based recommendations on the treatment of CIPN. Study Design: A systematic review of each treatment regimen in patients with CIPN. Methods: The literature on the treatment of CIPN published from 1990 to 2017 was searched and reviewed. The 2011 American Academy of Neurology Clinical Practice Guidelines Process Manual was used to grade the evidence and risk of bias. We reviewed and updated the recommendations of the ASCO in 2014, and evaluated new approaches for treating CIPN. Results: A total of 26 treatment options in 35 studies were identified. Among these, 7 successful RCTs, 6 failed RCTs, 18 prospective studies, and 4 retrospective studies were included. The included studies examined not only pharmacologic therapy but also other modalities, including laser therapy, scrambler therapy, magnetic field therapy and acupuncture, etc. Most of the included studies had small sample sizes, and short follow-up periods. Primary outcome measures were highly variable across the included studies. No studies were prematurely closed owing to its adverse effects. Limitations: The limitations of this systematic review included relatively poor homogeneous, with variations in timing of treatment, primary outcomes, and chemotherapeutic agents used. Conclusion: The evidence is considered of moderate benefit for duloxetine. Photobiomodulation, known as low level laser therapy, is considered of moderate benefit based on the evidence review. Evidence did not support the use of lamotrigine and topical KA (4% ketamine and 2% amitriptyline). The evidence for tricyclic antidepressants was inconclusive as amitriptyline showed no benefit but nortriptyline had insufficient evidence. Further research on CIPN treatment is needed with larger sample sizes, long-term follow-up, standardized outcome measurements, and standardized treatment timing.
引用
收藏
页码:571 / 592
页数:22
相关论文
共 70 条
[1]  
Addington J, 2016, F1000RES, P5
[2]   The effect of photobiomodulation on chemotherapy-induced peripheral neuropathy: A randomized, sham-controlled clinical trial [J].
Argenta, Peter A. ;
Baliman, Karla V. ;
Geller, Melissa A. ;
Carson, Linda F. ;
Ghebre, Rahel ;
Mullany, Sally A. ;
Teoh, Deanna G. K. ;
Winterhoff, Boris J. N. ;
Rivard, Colleen L. ;
Erickson, Britt K. .
GYNECOLOGIC ONCOLOGY, 2017, 144 (01) :159-166
[3]   A Pilot Study of Acupuncture in Treating Bortezomib-Induced Peripheral Neuropathy in Patients With Multiple Myeloma [J].
Bao, Ting ;
Goloubeva, Olga ;
Pelser, Colleen ;
Porter, Neil ;
Primrose, James ;
Hester, Lisa ;
Sadowska, Mariola ;
Lapidus, Rena ;
Medeiros, Michelle ;
Lao, Lixing ;
Dorsey, Susan G. ;
Badros, Ashraf Z. .
INTEGRATIVE CANCER THERAPIES, 2014, 13 (05) :396-404
[4]   A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA [J].
Barton, Debra L. ;
Wos, Edward J. ;
Qin, Rui ;
Mattar, Bassam I. ;
Green, Nathan Benjamin ;
Lanier, Keith S. ;
Bearden, James Dewitt, III ;
Kugler, John W. ;
Hoff, Kay L. ;
Reddy, Pavan S. ;
Rowland, Kendrith M., Jr. ;
Riepl, Mike ;
Christensen, Bradley ;
Loprinzi, Charles L. .
SUPPORTIVE CARE IN CANCER, 2011, 19 (06) :833-841
[5]   Chemotherapy-induced peripheral neuropathy and impact on quality of life 6 months after treatment with chemotherapy [J].
Beijers, Antoinetta ;
Mols, Floortje ;
Dercksen, Wouter ;
Driessen, Chantal ;
Vreugdenhil, Gerard .
JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2014, 12 (11) :401-406
[6]   Long-term course of oxaliplatin-induced polyneuropathy: a prospective 2-year follow-up study [J].
Briani, Chiara ;
Argyriou, Andreas A. ;
Izquierdo, Cristina ;
Velasco, Roser ;
Campagnolo, Marta ;
Alberti, Paola ;
Frigeni, Barbara ;
Cacciavillani, Mario ;
Bergamo, Francesca ;
Cortinovis, Diego ;
Cazzaniga, Marina ;
Bruna, Jordi ;
Cavaletti, Guido ;
Kalofonos, Haralabos P. .
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2014, 19 (04) :299-306
[7]   Evidence-based guideline: Treatment of painful diabetic neuropathy [J].
Bril, V. ;
England, J. ;
Franklin, G. M. ;
Backonja, M. ;
Cohen, J. ;
Del Toro, D. ;
Feldman, E. ;
Iverson, D. J. ;
Perkins, B. ;
Russell, J. W. ;
Zochodne, D. .
NEUROLOGY, 2011, 76 (20) :1758-1765
[8]   Controlled-release oxycodone for the treatment of bortezomib-induced neuropathic pain in patients with multiple myeloma [J].
Cartoni, Claudio ;
Brunetti, Gregorio Antonio ;
Federico, Vincenzo ;
Efficace, Fabio ;
Grammatico, Sara ;
Tendas, Andrea ;
Scaramucci, Laura ;
Cupelli, Luca ;
D'Elia, Gianna Maria ;
Truini, Andrea ;
Niscola, Pasquale ;
Petrucci, Maria Teresa .
SUPPORTIVE CARE IN CANCER, 2012, 20 (10) :2621-2626
[9]   The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings [J].
Cavaletti, G. ;
Cornblath, D. R. ;
Merkies, I. S. J. ;
Postma, T. J. ;
Rossi, E. ;
Frigeni, B. ;
Alberti, P. ;
Bruna, J. ;
Velasco, R. ;
Argyriou, A. A. ;
Kalofonos, H. P. ;
Psimaras, D. ;
Ricard, D. ;
Pace, A. ;
Galie, E. ;
Briani, C. ;
Dalla Torre, C. ;
Faber, C. G. ;
Lalisang, R. I. ;
Boogerd, W. ;
Brandsma, D. ;
Koeppen, S. ;
Hense, J. ;
Storey, D. ;
Kerrigan, S. ;
Schenone, A. ;
Fabbri, S. ;
Valsecchi, M. G. .
ANNALS OF ONCOLOGY, 2013, 24 (02) :454-462
[10]   Chemotherapy-Induced Peripheral Neurotoxicity assessment: A critical revision of the currently available tools [J].
Cavaletti, Guido ;
Frigeni, Barbara ;
Lanzani, Francesca ;
Mattavelli, Laura ;
Susani, Emanuela ;
Alberti, Paola ;
Cortinovis, Diego ;
Bidoli, Paolo .
EUROPEAN JOURNAL OF CANCER, 2010, 46 (03) :479-494